Target Name: NAA15
NCBI ID: G80155
Review Report on NAA15 Target / Biomarker Content of Review Report on NAA15 Target / Biomarker
NAA15
Other Name(s): MRD50 | Tubedown-1 | TBDN100 | Tbdn100 | Gastric cancer antigen Ga19 | protein tubedown-1 | NMDA receptor-regulated protein 1 | NAA15_HUMAN | TBDN | OTTHUMP00000174300 | gastric cancer antigen Ga19 | NARG1 | Protein tubedown-1 | Ga19 | NATH | Transcriptional coactivator tubedown-100 | tubedown-1 | N-alpha-acetyltransferase 15, NatA auxiliary subunit | NAT1P | NMDA receptor regulated 1 | N-terminal acetyltransferase | transcriptional coactivator tubedown-100 | OTTHUMP00000174301

Understanding NAA15: Potential Drug Target Or Biomarker

NAA15 (N-acetyl-浼?-actininyl-coenzyme A15) is a protein that is expressed in various tissues throughout the body. It is a key player in the intracellular signaling pathway known as the TOR signaling pathway, which regulates various cellular processes including cell growth, metabolism, and stress response. Despite its importance, little is known about NAA15, and it has not been extensively studied. However, there is evidence to suggest that NAA15 may be a drug target or biomarker, with potential implications for various diseases.

The TOR signaling pathway is a well-established biological pathway that plays a crucial role in various cellular processes. It is involved in the regulation of cell growth, metabolism, and stress response. The pathway is composed of several key components, including the protein kinase activating receptor (KIR), the adapter protein 1 (AP-1), and the transducer enzyme (TOR). NAA15 is one of the proteins that is associated with the TOR signaling pathway.

NAA15 is a 21-kDa protein that is expressed in various tissues throughout the body, including muscle, heart, liver, and kidney. It is a key player in the regulation of cellular processes, including cell growth, metabolism, and stress response. NAA15 functions as a negative regulator of the TOR signaling pathway, which means that it works to inhibit the activity of the TOR protein.

The TOR signaling pathway is a well-established biological pathway that plays a crucial role in various cellular processes. It is involved in the regulation of cell growth, metabolism, and stress response. The pathway is composed of several key components, including the protein kinase activating receptor (KIR), the adapter protein 1 (AP-1), and the transducer enzyme (TOR). NAA15 is one of the proteins that is associated with the TOR signaling pathway.

NAA15 is involved in the regulation of cellular processes that are critical for cell survival. For example, it is known to be involved in the regulation of cell cycle progression, cell growth, and apoptosis. NAA15 has been shown to play a role in the regulation of cell growth and apoptosis, and it is thought to be involved in the development of cancer.

In addition to its role in cell growth and apoptosis, NAA15 is also involved in the regulation of metabolism. For example, it has been shown to be involved in the regulation of energy metabolism and the detoxification of environmental toxins. NAA15 may also be involved in the regulation of inflammation, as it has been shown to play a role in the production of pro-inflammatory cytokines.

Despite its importance, little is known about NAA15. There are no known drugs that are specifically designed to target NAA15, and there is limited research on the potential implications of NAA15 as a drug target or biomarker. However, the potential implications of NAA15 as a drug target or biomarker are significant. If NAA15 is found to be involved in the regulation of cellular processes, it may be potential target for drugs that are designed to interfere with its activity. Additionally, if NAA15 is found to be involved in the regulation of cellular processes that are critical for human health, it may be potential biomarker for a variety of diseases.

In conclusion, NAA15 is a protein that is associated with the TOR signaling pathway. It is involved in the regulation of cellular processes that are critical for cell survival and metabolism, and it may be a potential drug target or biomarker. Further research is needed to fully understand the role of NAA15 in cellular processes and its potential implications as a drug target or biomarker.

Protein Name: N-alpha-acetyltransferase 15, NatA Auxiliary Subunit

Functions: Auxillary subunit of N-terminal acetyltransferase complexes which display alpha (N-terminal) acetyltransferase (NAT) activity (PubMed:15496142, PubMed:20154145, PubMed:29754825, PubMed:32042062). The NAT activity may be important for vascular, hematopoietic and neuronal growth and development (PubMed:15496142). Required to control retinal neovascularization in adult ocular endothelial cells (PubMed:11687548). In complex with XRCC6 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter (PubMed:12145306)

The "NAA15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NAA15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NAA16 | NAA20 | NAA25 | NAA30 | NAA35 | NAA38 | NAA40 | NAA50 | NAA60 | NAA80 | NAAA | NAALAD2 | NAALADL1 | NAALADL2 | NAALADL2-AS3 | NAB1 | NAB2 | NABP1 | NABP2 | NACA | NACA2 | NACA3P | NACA4P | NACAD | NACC1 | NACC2 | NAD(P)H dehydrogenase, quinone | NAD-Dependent Protein Deacetylase | NADH dehydrogenase (Complex I) | NADK | NADK2 | NADPH Oxidase | NADPH Oxidase Complex | NADSYN1 | NAE1 | NAF1 | NAG18 | NAGA | NAGK | NAGLU | NAGPA | NAGPA-AS1 | NAGS | NAIF1 | NAIP | NAIPP2 | NALCN | NALCN sodium channel complex | NALCN-AS1 | NALF1 | NALF2 | NALT1 | NAMA | NAMPT | NAMPTP1 | NANOG | NANOGNB | NANOGP1 | NANOGP8 | NANOS1 | NANOS2 | NANOS3 | NANP | NANS | NAP1L1 | NAP1L1P1 | NAP1L2 | NAP1L3 | NAP1L4 | NAP1L4P1 | NAP1L5 | NAP1L6P | NAPA | NAPA-AS1 | NAPB | NAPEPLD | NAPG | NAPRT | NAPSA | NAPSB | NARF | NARS1 | NARS2 | Nascent polypeptide-associated complex | NASP | NAT1 | NAT10 | NAT14 | NAT16 | NAT2 | NAT8 | NAT8B | NAT8L | NAT9 | NATD1 | Natural cytotoxicity triggering Receptor | NAV1 | NAV2 | NAV2-AS5 | NAV2-AS6